Intended purpose
The specific task, user, population, environment, and outcome a product is designed or claimed to support.
Why it matters: A product can be suitable for one intended purpose and unsuitable for another, even when the vendor name and model are the same.
Software as a medical device (SaMD)
Software intended for one or more medical purposes that is not part of a hardware medical device.
Why it matters: The intended purpose, not the marketing label, determines which regulatory, quality, evidence, and post-market questions a buyer must ask.
Clinical safety case
A structured argument, supported by evidence, that a health technology can be used safely in a defined clinical context with risks controlled.
Why it matters: A buyer needs accountable clinical ownership, hazards, mitigations, evidence, and an operational change process rather than a safety slogan.
Model drift
A change in data, population, workflow, prevalence, or performance that makes a model's prior validation less representative of current use.
Why it matters: Drift monitoring, thresholds, incident ownership, revalidation, and rollback should be part of the operating plan.
Human oversight
The people, workflow controls, review opportunities, escalation paths, and accountability that keep an AI-assisted decision within its safe boundary.
Why it matters: Human-in-the-loop is meaningful only when the person has context, time, authority, training, and a way to correct or reject output.
Ambient documentation
A workflow that captures a consented conversation or encounter context and produces a draft clinical note or administrative record for human review.
Why it matters: Measure edit burden, consent, retention, provenance, specialty performance, and final clinician accountability.
Revenue cycle management (RCM)
The operational processes that connect patient access, coding, billing, claims, payment, denials, and financial reporting.
Why it matters: An RCM automation claim needs a baseline, exception design, audit trail, payer context, and evidence of displaced work as well as cash impact.
Evidence maturity
How much relevant, current, independent, external, regulatory, or health-system evidence exists for the exact product, use, workflow, and market.
Why it matters: Evidence maturity is not a clinical superiority score and does not replace formal diligence or local validation.
Market status
The state of documented public evidence for a product's regulatory, deployment, support, language, procurement, and availability context in a named market.
Why it matters: Documented, limited, and verify states prevent a global vendor claim from being mistaken for current local authorisation or availability.